A case of methaemoglobinaemia following ingestion of an aniline-containing material is described. The detrimental effect of methylene blue, the classical antidote of methaemoglobinaemia, in a patient with glucose-6phosphate dehydrogenase deficiency is highlighted.
Methaemoglobinaemia may be hereditary or acquired. Acquired methaemoglobinaemia may be secondary to accidental or intentional exposure to substances that carry the potential of increasing the rate of haem oxidation to the extent that it overwhelms the capacity of erythrocytes to maintain haemoglobin in the reduced state. Several agents like nitrates, nitrites, aniline, phenacetin, sulphonamides, nitrobenzene etc. have been implicated 1 . Aniline (C 6 H 5 NH 2 ), an aromatic amine, is commonly used in the manufacture of rubber processing chemicals, lacquers, wood stains, pigments and dyes used in printing material 2 . It is metabolised to a variety of substances capable of generating methaemoglobin. Methylene blue (tetramethylthionine chloride trihydrate) is the established antidote for methaemoglobinaemia. Its failure to combat cyanosis should suggest the possibility of glucose-6-phosphate adenine dinucleotide phosphate, reduced form 3 .
CASE HISTORY
A 23-year-old woman was brought to the emergency room 30 minutes after having consumed 20 to 30 ml of aniline-containing printing material. On physical examination she was found unconscious responding only to painful stimuli. Her pupils were semi-dilated, sluggishly reacting to light. She had both peripheral and central cyanosis in the absence of clubbing. No history of cardiopulmonary disease or previous hospitalisation could be elicited from relatives.
Her trachea was immediately intubated and intermittent positive pressure ventilation instituted and gastric lavage undertaken.
The colour of blood was noted to be chocolate brown. Oxygen saturation measured using Ohmeda Biox pulse oximeter (SpO 2 ) was 81%. Arterial blood gas analysis during ventilation at FiO 2 1.0 showed pH 7.46, P a O 2 51.5 kPa, P a CO 2 3.6 kPa and calculated oxygen saturation 99.2%.
A presumptive diagnosis of methaemoglobinaemia secondary to aniline poisoning was made in view of the chocolate brown colour of blood, a peculiar greyish cyanosis unresponsive to oxygen therapy, a reduced measured oxygen saturation (SpO 2 81%) and a normal calculated oxygen saturation (99.2% on blood gas analysis). The colour of blood did not change on vigorous shaking or after bubbling oxygen paper remained dark brown. The methaemoglobin level was 34%.
Intravenous methylene blue (1%) 50 mg in normal saline was given over 10 minutes. During its injection a fall in SpO 2 to 62% was observed. This was expected as methylene blue has the same absorption wavelength as reduced haemoglobin. Intravenous ascorbic acid 500 mg in 5% dextrose over 20 minutes to be given 12 hourly was also commenced.
No clinical improvement was observed even after one hour of treatment with methylene blue. A qualitative G6PD screening test using the methaemoglobin reduction method was done, the result of which Hence a repeat dose of methylene blue was omitted. An increased bluish-grey discolouration of skin was observed following methylene blue treatment and lasted for three days.
She developed haemolysis within 24 hours of exposure to aniline and methylene blue treatment and this required transfusion.
Her trachea could be extubated after 72 hours, when both clinical and blood gas parameters showed improvement. Oxygen therapy was continued using a facemask. The cyanosis persisted and completely disappeared by the 14th day when the patient was discharged.
DISCUSSION
Under normal conditions, the methaemoglobin level is maintained to <1% by enzyme systems in red blood cells. These enzyme systems are the nicotinamide-adenine dinucleotide, reduced form (NADH)-methaemoglobin reductase which reduces 95% of oxidised haemoglobin in vivo using cytochrome b 5 as an electron carrier 4 and the NADPH methaemoglobin reductase which gets activated only in the presence of an exogenous electron carrier such as methylene blue. Glutathione and ascorbic acid reduce methaemoglobin directly but are quantitatively of minor importance [4] [5] [6] [7] .
Agents like nitrates, nitrites, chlorates and quinones oxidise haem iron directly. Aniline, on the other hand, undergoes biochemical transformation to active intermediate compounds, which are responsible for methaemoglobin formation 1 . Phenylhydroxylamine is an important metabolite of aniline capable of methaemoglobin formation 3 .
Methylene blue is the mainstay of treatment of methaemoglobinaemia. It is given whenever symptoms of hypoxia are present, irrespective of the methaemoglobin levels. Usually the methaemoglobin levels of more than 30% warrant treatment, but in the presence of anaemia, symptoms of hypoxia may occur at lower levels and require treatment.
Methylene blue reduces the half-life of methaemoglobin from 15 to 20 hours to 40 to 90 minutes 8 . It is given in a dose of 1 mg/kg over 5 to 10 minutes. Repeat doses may be given; however, a cumulative dose exceeding 7 mg/kg may induce toxic effects. It may cause methaemoglobin formation and haemolysis due to its inherent oxidant properties 3 .
The action of methylene blue depends on its reduction to leucomethylene blue, which then directly reduces methaemoglobin to haemoglobin. The reduction of methylene blue to leuco-methylene blue requires the NADPH-dependent enzyme NADPH methaemoglobin reductase. The only RBC source of reduced NADPH is the hexose monophosphate shunt pathway, the initial step of which is catalysed by enzyme G6PD 9 . Thus in G6PD is unable to reduce methaemoglobin.
Most female carriers are asymptomatic 10 . G6PD seen in 200 million people across the world. Although global in distribution, it is seen in greatest frequency in tropical and subtropical zones of the eastern hemisphere 9 . The frequency in India has been reported to be 4-19% (WHO), most common in northern and western parts of India.
The failure of our patient to respond to methylene blue treatment could perhaps be attributed to a lack The bluish grey discolouration was probably due to an inability of conversion of methylene blue in tissues to colourless leucomethylene blue due to her G6PD Ascorbic acid was added to our treatment protocol as it directly reduces methaemoglobin to haemoglobin, irrespective of the G6PD status. Also, by causing acidosis, it improves oxygen delivery to the tissues due to a shift in oxyhaemoglobin dissociation curve to the right 8 .
Increased oxidant stress caused by exposure to aniline, its metabolites, methylene blue and the lack of G6PD protective effect against this oxidant stress may have contributed towards inducing haemolysis in our patient. not be administered. In these patients, if the clinical condition deteriorates or does not improve with supportive therapy, other treatment modalities such as exchange transfusion, haemodialysis and hyperbaric oxygen should be considered.
